Influence
February 13, 2020

Regenstrief researchers leading core of national research incubator

Drs. Callahan and Torke are leading a core of a national Alzheimer's research incubator.

Regenstrief researchers Christopher M. Callahan, M.D., and Alexia M. Torke, M.D., are leading the training core of a major national research incubator with the goal of improving healthcare and quality of life for people with Alzheimer’s disease and related dementias. Dr. Callahan and Dr. Torke will develop and coordinate a two-year junior career development award program to train researchers to conduct embedded pragmatic clinical trials in people living with dementia. The scientists trained will help to develop and test solutions to improve care for the growing population of people suffering from the disease.

Read more.

Related News

IU announces $138 million Lilly Endowment grant, launches partnership to accelerate bioscience innovation

IU announces $138 million Lilly Endowment grant, launches partnership to accelerate bioscience innovation

Regenstrief one of the partners expected to drive advancements and commercialization in biosciences  Regenstrief Institute will partner with Indiana

Thomas Imperiale, MD

Is the Multitarget Stool DNA Test Just a Better “FIT” for Colorectal Cancer Screening?

Published in the journal JAMA Internal Medicine. Here is a link to the article. Regenstrief Institute authors: Tom Imperiale,

Alexia Torke, MD, MS, and George Fitchett, DMin, PhD

Caring for the emotional and spiritual needs of family members of ICU patients

INDIANAPOLIS – Family members of intensive care unit (ICU) patients often experience psychological and spiritual distress as they deal

Randall Grout, MD

Informaticians apply tools and techniques to eliminate ambiguity and better implement guidelines and policies in pediatric care

Policy implementation experts’ model can be reproduced and repeated, in many different practices For the last three decades, medical